abnormal&#32

5 trials

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Zhongda Hospital Affiliated to Southeast University, Zhongshan Hospital, Fudan University, Shandong Cancer Hospital

Conditions

PA-HSOSPulmonary noduleslung cancerpleural effusionprimary liver cancer

Early Phase 1

Application of MDA TEST in lung cancer screening on high-risk populations: a mult-center, perspective, diagnostic study

Active, not recruitingChiCTR2000030437

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitylung cancer

Start: 2020-03-31Updated: 2020-03-02

Artificial Intelligence and Circulating Abnormal Cells: Auxiliary Diagnosis in Differentiating Benign From Malignant Pulmonary Nodule in China

Active, not recruitingChiCTR2000034812

Zhongda Hospital Affiliated to Southeast UniversityPulmonary nodules

Start: 2020-07-31Updated: 2020-07-27

Application of circulating abnormal cell (CAC) detection in the differential diagnosis of benign and malignant pleural effusions

Active, not recruitingChiCTR2000035946

Zhongshan Hospital, Fudan Universitypleural effusion

Start: 2020-09-01Updated: 2020-08-24

Clinical trial of abnormal prothrombin (PIVKA-II) assay kit (magnetic particle chemiluminescence method)

Active, not recruitingChiCTR2100048500

Shandong Cancer Hospitalprimary liver cancer

Start: 2021-08-01Updated: 2022-03-21

Unknown Phase

Diagnostic value of “Nanjing Criteria” for patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome:a diagnoctic test.

RecruitingChiCTR1900020784

The Affiliated Drum Tower Hospital of Nanjing University Medical SchoolPA-HSOS

Start: 2019-01-16Updated: 2019-01-28

Related Papers

Validation of the Nanjing Criteria for Diagnosing Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstruction Syndrome.

2021-03-3113 citations